Current Edition

Upcoming Events

Advertisement

news

Almac Group releases details of £80 million expansion at global headquarters in Northern Ireland 

Expansion will provide a 140,000ft2 capacity increase for development and manufacturing facilities The Almac Group has today announced details of an £80 mill...
Continue Reading →
news

Almac Appoints Global Energy Manager as part of  ongoing commitment to net zero strategy  

The Almac Group has announced the appointment of Ramees Raja as Global Energy Manager. This is a new role that will drive actions to support Almac’s commitment to...
Continue Reading →
news

Merck allies with Daiichi Sankyo in major bet on antibody cancer drugs

Merck & Co. is making a major investment in the future of its cancer drug business, agreeing to one of the largest pharmaceutical licensing deals by value to sec...
Continue Reading →
news

Laronde, Senda Biosciences merge to create new Flagship company

Dive Brief: Flagship Pioneering-launched startups Laronde and Senda Biosciences are merging to form a new biotechnology company called Sail Biomedicines, the com...
Continue Reading →
news

Beam to lay off 100 employees, seek partners in research restructuring

Beam Therapeutics, the base editing biotechnology company, on Thursday said it will lay off 100 employees, pause some research and look for partners on a few of its ...
Continue Reading →
news

Aldena Therapeutics Selects PCI Pharma Services to Manufacture and Distribute Innovative Investigational Treatment for Dermatological Diseases

World-leading CDMO Offers Highly Specialized Experience Bringing Complex Formulations to Market Quickly and Will Support Clinical Trials of Aldena’s siRNA-based Inje...
Continue Reading →
news

Pfizer wins FDA approval for its $7B colitis drug

Dive Brief: The Food and Drug Administration on Friday approved Pfizer’s Velsipity to treat ulcerative colitis, making it the second pill of its type cleared for...
Continue Reading →
news

Pfizer to cut costs, lay off staff on waning demand for COVID products

Pfizer said on Friday afternoon it plans to cut billions of dollars in spending and lay off staff as it adjusts to lower demand for its COVID-19 drug Paxlovid and va...
Continue Reading →
news

Novo Nordisk’s Ozempic shows kidney benefit in large study

Novo Nordisk will stop a large clinical trial testing its diabetes drug Ozempic after an early look at the data found treatment had a kidney benefit, the company sai...
Continue Reading →
news

After summer slump, biotech M&A has a good week

This summer, large biotechnology deals took a vacation. In the three-month stretch from July through September, just six acquisitions worth at least $50 million w...
Continue Reading →